ArticleGynecologic oncology reports2019

Treatment of neuroendocrine carcinoma of the cervix with a PARP inhibitor based on next generation sequencing.

Peter G Rose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.